Gene expression analysis of ischaemia and reperfusion in human microsurgical free muscle tissue transfer

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 4, 2011, Pages 983-993

  Dragu, Adrian ^a   Schnürer, Stefan ^a   Surmann Schmitt, Cordula ^a   von der Mark, Klaus ^a   Stürzl, Michael ^a   Unglaub, Frank ^a   Wolf, Maya B ^a   Leffler, Mareike ^a   Beier, Justus P ^a   Kneser, Ulrich ^a   Horch, Raymund E ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Gene arrays; Gene expression; Human tissue; Hypoxia; Ischaemia; Muscle free flaps; Reperfusion

Indexed keywords

EID: 79955655247     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01061.x     Document Type: Article

References (55)

1. Arkudas A, Tjiawi J, Saumweber A, et al Evaluation of blood vessel ingrowth in fibrin gel subject to type and concentration of growth factors. J Cell Mol Med. 2008; 13: 2864-74.
2. Bleiziffer O, Horch RE, Hammon M, et al T17b murine embryonal endothelial progenitor cells can be induced towards both proliferation and differentiation in a fibrin matrix. J Cell Mol Med. 2009; 13: 926-35.
3. Hutmacher DW, Horch RE, Loessner D, et al Translating tissue engineering technology platforms into cancer research. J Cell Mol Med. 2009; 13: 1417-27.
4. Polykandriotis E, Euler S, Arkudas A, et al Regression and persistence: remodelling in a tissue engineered axial vascular assembly. J Cell Mol Med. 2009. Doi:
5. Wallmichrath J, Stark GB, Kneser U, et al Epidermal growth factor (EGF) transfection of human bone marrow stromal cells in bone tissue engineering. J Cell Mol Med. 2009; 13: 2593-601
6. Beier JP, Klumpp D, Rudisile M, et al Collagen matrices from sponge to nano: new perspectives for tissue engineering of skeletal muscle. BMC Biotechnol. 2009; 9: 34.
7. Arkudas A, Tjiawi J, Saumweber A, et al Evaluation of blood vessel ingrowth in fibrin gel subject to type and concentration of growth factors. J Cell Mol Med. 2009; 13: 2864-74.
8. Bizeau A, Guelfucci B, Giovanni A, et al 15 years experience with microvascular free tissue transfer for repair of head and neck cancer defects. Ann Otolaryngol Chir Cervicofac. 2002; 119: 31-8.
9. Bui DT, Cordeiro PG, Hu QY, et al Free flap reexploration: indications, treatment, and outcomes in 1193 free flaps. Plast Reconstr Surg. 2007; 119: 2092-100.
10. Vega S, Smartt JM, Jr., Jiang S, et al 500 Consecutive patients with free TRAM flap breast reconstruction: a single surgeon's experience. Plast Reconstr Surg. 2008; 122: 329-39.
11. Karsenti G, Le Manach Y, Bouvier S, et al Statins: a new pharmacological agent for free flap surgery J Plast Reconstr Aesthet Surg. 2009. Doi:
12. Ashrafian H, Dwivedi G, Senior R. Assessing myocardial perfusion after myocardial infarction. PLoS Med. 2006; 3: e131.
13. Grenz A, Osswald H, Eckle T, et al The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med. 2008; 5: e137.
14. Baumeister S, Ofer N, Kleist C, et al Reduction of skeletal muscle injury in composite tissue allotransplantation by heat stress preconditioning. Plast Reconstr Surg. 2004; 114: 1832-41.
15. Chen ZG, Persons B, Lin L, et al Vascular endothelial growth factor upregulates inducible nitric oxide synthase expression in the muscle flap ischemia model in the rat. J Reconstr Microsurg. 2009; 25: 219-25.
16. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol. 1995; 146: 3-15.
17. Van Cruchten S, Van Den Broeck W. Morphological and biochemical aspects of apoptosis, oncosis and necrosis. Anat Histol Embryol. 2002; 31: 214-23.
18. Wang WZ, Fang XH, Stephenson LL, et al Ischemia/reperfusion-induced necrosis and apoptosis in the cells isolated from rat skeletal muscle. J Orthop Res. 2008; 26: 351-6.
19. Siemionow M, Arslan E. Ischemia/reperfusion injury: a review in relation to free tissue transfers. Microsurgery. 2004; 24: 468-75.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162: 156-9.
21. Surmann-Schmitt C, Widmann N, Mallein-Gerin F, et al Stable subclones of the chondrogenic murine cell line MC615 mimic distinct stages of chondrocyte differentiation. J Cell Biochem. 2009; 108: 589-99.
22. Surmann-Schmitt C, Widmann N, Dietz U, et al Wif-1 is expressed at cartilage-mesenchyme interfaces and impedes Wnt3a-mediated inhibition of chondrogenesis. J Cell Sci. 2009; 122: 3627-37.
23. Unglaub F, Thomas SB, Wolf MB, et al Cartilage cell proliferation in degenerative TFCC wrist lesions. Arch Orthop Trauma Surg. 2009. Doi:
24. Hildenbrand R, Gandhari M, Stroebel P, et al The urokinase-system-role of cell proliferation and apoptosis. Histol Histopathol. 2008; 23: 227-36.
25. Hughes CC. Endothelial-stromal interactions in angiogenesis. Curr Opin Hematol. 2008; 15: 204-9.
26. Rijken DC, Lijnen HR. New insights into the molecular mechanisms of the fibrinolytic system. J Thromb Haemost. 2009; 7: 4-13.
27. Bryer SC, Fantuzzi G, Van Rooijen N, et al Urokinase-type plasminogen activator plays essential roles in macrophage chemotaxis and skeletal muscle regeneration. J Immunol. 2008; 180: 1179-88.
28. Lluis F, Roma J, Suelves M, et al Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo. Blood. 2001; 97: 1703-11.
29. th ed. New York Saunders; 2007.
30. Unglaub F, Thomas SB, Kroeber MW, et al Apoptotic pathways in degenerative disk lesions in the wrist. Arthroscopy. 2009; 25: 1380-6.
31. Scarabelli TM, Stephanou A, Pasini E, et al Different signaling pathways induce apoptosis in endothelial cells and cardiac myocytes during ischemia/reperfusion injury. Circ Res. 2002; 90: 745-8.
32. Kang TB, Ben-Moshe T, Varfolomeev EE, et al Caspase-8 serves both apoptotic and nonapoptotic roles. J Immunol. 2004; 173: 2976-84.
33. Scharner D, Rossig L, Carmona G, et al Caspase-8 is involved in neovascularization-promoting progenitor cell functions. Arterioscler Thromb Vasc Biol. 2009; 29: 571-8.
34. Xiao Q, Xu Q. Caspase-8, a double-edged sword for EPC functioning. Arterioscler Thromb Vasc Biol. 2009; 29: 444-6.
35. Fischer B, Coelho D, Dufour P, et al Caspase 8-mediated cleavage of the pro-apoptotic BCL-2 family member BID in p53-dependent apoptosis. Biochem Biophys Res Commun. 2003; 306: 516-22.
36. Yin XM. Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways. Cell Res. 2000; 10: 161-7.
37. Zhao Y, Ding WX, Qian T, et al Bid activates multiple mitochondrial apoptotic mechanisms in primary hepatocytes after death receptor engagement. Gastroenterology. 2003; 125: 854-67.
38. Broughton BR, Reutens DC, Sobey CG. Apoptotic mechanisms after cerebral ischemia. Stroke. 2009; 40: e331-9.
39. Baggiolini M, Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett. 1992; 307: 97-101.
40. Hua HT, Al-Badawi H, Entabi F, et al CXC chemokine expression and synthesis in skeletal muscle during ischemia/reperfusion. J Vasc Surg. 2005; 42: 337-43.
41. Huda R, Solanki DR, Mathru M. Inflammatory and redox responses to ischaemia/reperfusion in human skeletal muscle. Clin Sci. 2004; 107: 497-503.
42. Gabrielsen A, Lawler PR, Yongzhong W, et al Gene expression signals involved in ischemic injury, extracellular matrix composition and fibrosis defined by global mRNA profiling of the human left ventricular myocardium. J Mol Cell Cardiol. 2007; 42: 870-83.
43. Gebhardt C, Nemeth J, Angel P, et al S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol. 2006; 72: 1622-31.
44. Mortensen OH, Andersen K, Fischer C, et al Calprotectin is released from human skeletal muscle tissue during exercise. J Physiol. 2008; 586: 3551-62.
45. Dragu A. Kontraktilität, Kontraktur und BNP-Expression unter hypoxischen Bedingungen und Glukoseentzug an isolierten menschlichen myokardialen Trabekeln. 95 Bl Ill, graph Darst; (ger / dt) Freiburg im Breisgau, Univ, Diss., 2000
46. Copland JA, Pardini AW, Wood TG, et al IGF-1 controls GLUT3 expression in muscle via the transcriptional factor Sp1. Biochim Biophys Acta. 2007; 1769: 631-40.
47. Vannucci SJ, Reinhart R, Maher F, et al Alterations in GLUT1 and GLUT3 glucose transporter gene expression following unilateral hypoxia-ischemia in the immature rat brain. Brain Res Dev Brain Res. 1998; 107: 255-64.
48. Hartman MG, Lu D, Kim ML, et al Role for activating transcription factor 3 in stress-induced beta-cell apoptosis. Mol Cell Biol. 2004; 24: 5721-32.
49. Huang X, Li X, Guo B. KLF6 induces apoptosis in prostate cancer cells through up-regulation of ATF3. J Biol Chem. 2008; 283: 29795-801.
50. Lu D, Wolfgang CD, Hai T. Activating transcription factor 3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis. J Biol Chem. 2006; 281: 10473-81.
51. Jin K, Mao XO, Sun Y, et al Heparin-binding epidermal growth factor-like growth factor: hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo. J Neurosci. 2002; 22: 5365-73.
52. Tanaka N, Sasahara M, Ohno M, et al Heparin-binding epidermal growth factor-like growth factor mRNA expression in neonatal rat brain with hypoxic/ischemic injury. Brain Res. 1999; 827: 130-8.
53. Weuste M, Wurm A, Iandiev I, et al HB-EGF: increase in the ischemic rat retina and inhibition of osmotic glial cell swelling. Biochem Biophys Res Commun. 2006; 347: 310-8.
54. Chalothorn D, Moore SM, Zhang H, et al Heparin-binding epidermal growth factor-like growth factor, collateral vessel development, and angiogenesis in skeletal muscle ischemia. Arterioscler Thromb Vasc Biol. 2005; 25: 1884-90.
55. Mehta VB, Zhou Y, Radulescu A, et al HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis. Growth Factors. 2008; 26: 301-15.